The Product Problem: Pathways for Making Misoprostol Available for Postpartum Hemorrhage
Misoprostol for Treatment of Postpartum Hemorrhage
Postpartum Hemorrhage Program Brief
Medical Abortion Program Brief
Pregnancy Failure and Miscarriage Program Brief
Fever after treatment of postpartum hemorrhage
Blood Loss After Vaginal Delivery
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
Annotated Bibliography - Misoprostol for Early Abortion
Reference List - Misoprostol for Incomplete Abortion and Miscarriage
Policy and Advocacy Activities Brief
Misoprostol for Incomplete Abortion and Miscarriage
PPH Misoprostol Adjunct Treatment Study
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Treatment of incomplete abortion and miscarriage with misoprostol
Misoprostol to treat missed abortion in the first trimester
Supervision for use of mifepristone medical abortion
Misoprostol and Teratogenicity: Reviewing the Evidence
Misoprostol for Prevention of Postpartum Hemorrhage
Reference List - Misoprostol for Prevention of Postpartum Hemorrhage
Postpartum Hemorrhage: A Challenge for Safe Motherhood
Postpartum Hemorrhage: Responding to the Challenge
Misoprostol PPH Treatment Study
PPH Prevention Study in Pakistan
PPH Treatment Study in Pakistan
Misoprostol: A New Addition to Post Abortion Care
Outlook Newsletter on Hormonal Contraception and HIV
FAQs on Fatal Infection and Medical Abortion - Technical Version
FAQs on Fatal Infection and Medical Abortion - Summary
Misoprostol for Women’s Health
Route of Misoprostol Administration
Treatment of postpartum hemorrhage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Reproductive intentions among HIV-positive women and men
Misoprostol for incomplete abortion in Tanzania
Misoprostol for incomplete abortion in Burkina Faso
Perspectives on reproductive decision-making amongst HIV-infected individuals
Misoprostol for incomplete abortion in Mozambique
The supreme court and the partial-birth abortion ban act of 2003
Methotrexate compared to misoprostol alone for early medical abortion
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Use of sequential serum hCG and sonography for medical abortion only when indicated
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Materials Development Activities Brief
Social Science Research Activities Brief
Technical Assistance Activities Brief
Training and Education Activities Brief
STIs/ HIV/ Infectious Disease Program Brief
Abortion in the Middle East and North Africa
Expanding Choice in Abortion Services in Armenia
Two distinct oral routes of misoprostol in mifepristone medical abortion
Integrating medical abortion into safe abortion services in South Africa
Community-based kangaroo mother care to prevent neonatal and infant mortality
Clostridium sordellii infection in medical abortion
Regimens of misoprostol with mifepristone for early medical abortion
Abortion and sex determination
Improving Current Therapies and Exploring New Options in Abortifacient Technology
Mifepristone medical abortion in Albania
Sublingual misoprostol after mifepristone
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Sublingual misoprostol for incomplete abortion
Increasing women’s choices in medical abortion in Turkey
Non-physician clinicians can safely provide first trimester medical abortion
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Acceptability and feasibility of medical abortion in Nepal
Annotated Bibliography - Mifepristone Medical Abortion
Home administration of misoprostol for early medical abortion in India
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
ICMA Third International Conference
Alternatives to Routine Follow-Up for Early Medical Abortion
High fever following postpartum administration of sublingual misoprostol
What measured blood loss tells us about postpartum bleeding
Misoprostol, Abortion, and the Law
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives
Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt
Abortion With Self-Administered Misoprostol: A Guide For Women
Self-induction of abortion among women in the United States
Buccal vs. sublingual misoprostol after mifepristone for medical abortion
Alternatives to routine ultrasound for eligibility assessment prior to medical abortion
Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana
Pericoital Oral Contraception with Levonorgestrel: A Systematic Review
Exploration of a new procedure for sterilization
Introduction and provision of medical abortion: A tale of two countries
Medical abortion for adolescents
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion
Review of the Literature on Patient Satisfaction with Early Medical Abortion
Oral Misoprostol for the Management of Incomplete Abortion in Ecuador